Immune-Checkpoint Inhibitors in B-Cell Lymphoma

SIMPLE SUMMARY: Immune-based treatment strategies, which include immune checkpoint inhibition, have recently become a new frontier for the treatment of B-cell-derived lymphoma. Whereas checkpoint inhibition has given oncologists and patients hope in specific lymphoma subtypes like Hodgkin lymphoma,...

Descripción completa

Detalles Bibliográficos
Autores principales: Armengol, Marc, Santos, Juliana Carvalho, Fernández-Serrano, Miranda, Profitós-Pelejà, Núria, Ribeiro, Marcelo Lima, Roué, Gaël
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827333/
https://www.ncbi.nlm.nih.gov/pubmed/33430146
http://dx.doi.org/10.3390/cancers13020214

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827333/
https://www.ncbi.nlm.nih.gov/pubmed/33430146
http://dx.doi.org/10.3390/cancers13020214

Ejemplares similares